UNSPSC 51273805: Antipyrine/benzocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT400. This VA Drug Class (OT400) classifies this compound as belonging to the group ANALGESICS, TOPICAL OTIC.

UNSPSC 51273805 Antipyrine/benzocaine, a Commodity code, does not align with the recent state and local opportunities tagged under it. The three most recent solicitations—from Seminole County, Florida; Texas Health and Human Services Commission; and Minnesota Multistate Cooperative Purchasing Alliance—focus on naloxone procurement, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products, respectively. None of these opportunities specifically source antipyrine/benzocaine formulations. The mismatch suggests either miscoding at the issuing-body level or that antipyrine/benzocaine procurement occurs through broader pharmaceutical acquisition vehicles rather than narrow commodity solicitations. State and local health departments and cooperative purchasing alliances appear to be the primary issuing bodies when pharmaceutical procurement does occur, but the code shows little relevant recent activity aligned to its actual scope.

Without recent opportunities directly soliciting antipyrine/benzocaine products, it is not possible to characterize the geographic spread, issuing-body concentration, or representative recent work under this code. A business development professional evaluating whether to pursue this code should monitor for future RFPs from state pharmacy programs, county health departments, and regional cooperative purchasing organizations, but should not assume that recent activity under this UNSPSC number reflects actual market demand for this specific ingredient or formulation.